Clinical trials
Completed Biliary Tract Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Zhongshan Hospital | 3 |
| ASLAN Pharmaceuticals | 2 |
| Fudan University | 2 |
| Peking Union Medical College Hospital | 2 |
| 3D Medicines (Sichuan) Co., Ltd. | 1 |
| Aiping Zhou | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Beijing Friendship Hospital | 1 |
| China Medical University, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 28 |
| Cholangiocarcinoma | 9 |
| Gallbladder Neoplasms | 7 |
| Neoplasms | 3 |
| Bile Duct Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Thyroid Neoplasms | 2 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.